settings and nurse-reported exposure to chemotherapy. BMJ Quality and Safety, 21 (9), 753–759. doi:10.1136/bmjqs-2011-000178 Friese, C. R., McArdle, C., Zhao, T., Sun, D., Spasojevic, I., Polovich, M. e McCullagh, M. C. (2015). Antineoplastic drug exposure in an ambulatory setting: A pilot study. Cancer Nursing, 38 (2), 111–117. doi:10.1097/NCC.0000000000000143 Friese, C. R., McCullagh, M. C. e Sutcliffe, K. (2015). Handle with care: The known and unknown risks to nurses who handle hazardous drugs. American Nurse Today, 10 (1), 41–42. Gilani, S. e Giridharan, S. (2014). Is it safe for pregnant health-care professionals to handle cytotoxic drugs? A review of the literature and recommendations. Ecancermedicalscience, 8, 418. doi:10.3332/ ecancer.2014.418 Gonzalez, R. e Massoomi, F. (2010). Manufacturers’ recommendations for handling spilled hazardous drugs. American Journal of Health-System Pharmacy, 67 (23), 1985–1986. doi:10.2146/ajhp100137 Goodin, S. (2007b). Safe handling of oral chemo agents in community settings. Pharmacy Times, 9, 1–6. Extraído de: http://www. pharmacytimes.com/publications/issue/2007/2007-09/2007-09-6789 International Society of Pharmacy Practitioners. (2007). Hierarchic order in protection measures. Journal of Oncology Pharmacy Practice, 13, 15–16. doi:10.1177/10781552070130030106 Jacobson, J. O., Polovich, M., Gilmore, T. R., Schulmeister, L., Esper, P., Lefebvre, K. B. e Neuss, M. N. (2012). Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: Expanding to include the inpatient setting. Journal of Oncology Practice, 8 (1), 2–6. doi:10.1200/JOP.2011.000339 Kiffmeyer, T. K., Kube, C., Opiolka, S., Schmidt, K. G., Schöppe, G. e Sessink, P. J. (2002). Vapour pressures, evaporation behavior and airborne concentrations of hazardous drugs: Implications for occupational safety. Pharmaceutical Journal, 268, 331–337. Kline, N. E., Bryant, R., Carlson, C., Hooke, M. C. e Nixon, C. (2014). Essentials of pediatric hematology/oncology nursing: A core curriculum (4 a ed.). Chicago, IL: Association of Pediatric Hematology/Oncology Nurses. Kopp, B., Schierl, R. e Nowak, D. (2013). Evaluation of work practices and surface contamination with antineoplastic drugs in outpatient oncology health care settings. International Archives of Occupational and Environmental Health, 86 (1), 47–55. doi:10.1007/ s00420-012-0742-z Looper, K., Winchester, K., Robinson, D., Price, A., Langley, R., Martin, G., . . . Flake, S. (2015). Best practices for chemotherapy administration in pediatric oncology: Quality and safety process improvements. Journal of Pediatric Oncology Nursing, 33 (3), 165-172. doi:10.1177/1043454215610490 Mahar, K. (2008). Practical applications: Overcoming barriers to chemotherapy safety in nursing. The Oncology Nurse-APN/PA, 1 (Suppl.), 2. Mansur, J. (2016). Improving safe handling practices for hazardous drugs . Joint Commission Resources. Extraído de: http://www.jcrinc. com/safe-handling-of-hazardous-drugs/ Martin, S. (2005). Chemotherapy handling and effects among nurses and their offspring [Abstract]. Oncology Nursing Forum, 32 (2), 425. Martin, S. e Larson, E. (2003). Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncology Nursing Forum, 30 (4), 575–581. doi:10.1188/03.ONF.575-581 Matsumoto, K., Naito, T., Hori, K., Suzuki, N., Miyamoto, Y., Takashina, Y., . . . Kawakami, J. (2010). Surveillance of workplace contamination and occupational exposure to antineoplastic agents in a hospital setting: Establishment of a monitoring method using doxorubicin. Yakugaku Zasshi, 130 (3), 431–439. doi:10.1248/yakushi.130.431 Moore, S. (2007). Facilitating oral chemotherapy treatment and compliance through patient/family focused education. Cancer Nursing, 30 (2), 112–121. doi:10.1097/01.NCC.0000265009.33053.2d
National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings (DHHS NIOSH Publication Number 2004-165). Extraído de: www.cdc.gov/niosh/docs/2004-165/ National Institute for Occupational Safety and Health. (2016). NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, 2016 (DHHS NIOSH Publication Number 2016-161). Cincinnati, OH: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. Neuss, M. N., Gilmore, T. R., Belderson, K. M., Billett, A. L., Conti- Kalchik, T., Harvey, B. E., . . . Polovich M. (2017). 2016 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards, including standards for pediatric oncology. Oncology Nursing Forum, 44 (1), 31–43. doi:10.1188/17.ONF.31-43 Occupational Safety and Health Administration. (1999). OSHA technical manual, TED 1-0.15A (section VI, Chapter 2). Extraído de: www. osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html Occupational Safety and Health Administration. (2004). Code of Federal Regulations. Title 29, Labor: Subpart: General: Definitions (Title 29, Part 29CFR 1910.20). Washington, DC: U.S. Government Printing Office. Occupational Safety and Health Administration (retrieved 2017). Controlling occupational exposure to hazardous drugs . Extraído de: https://www.osha.gov/SLTC/hazardousdrugs/controlling_occex_ hazardousdrugs.html#spills Page, M. R. (2016). USP <800>: Key changes and additions to USP <797>. Specialty Pharmacy Times. Extraído de: http://www.specialtypharmacytimes.com/print.php?url=/ publications/speciality-pharmacy-times/2016/february-2016/ USP-800-Key-Changes-and-Additions-to-USP-797 Polovich, M. (Ed.). (2011). Safe handling of hazardous drugs (2nd ed.). Pittsburgh, PA: Oncology Nursing Society. Polovich, M. (2016). Minimizing occupational exposure to antineoplastic agents. Journal of Infusion Nursing, 39 (5), 307–313. doi:10.1097/ NAN.000000000000018 Polovich, M. (2017). U.S. Pharmacopeial Chapter <800>: Be ready to comply by July 2018. Clinical Journal of Oncology Nursing, 21, 116– 119. doi:10.1188/17.CJON.116-119 Polovich, M., Olsen, M. e LeFebvre, K. B. (Eds.). (2014). Chemotherapy and biotherapy guidelines and recommendations for practice (4th ed.). Pittsburgh, PA: Oncology Nursing Society. Power, L. A. e Polovich, M. (2016). Safe handling of hazardous drugs: Reviewing standards for worker protection. (2016). Pharmacy Practice News . Extraído de: http://www.pharmacypracticenews.com/ download/Safehandling_PPNSE16r_WM.pdf Ritchie, M. A., McAdams, C. e Fritz, N. (2000). Exposure risk in the handling and administration of chemotherapy agents: A review and synthesis of the literature. Worldviews on Evidence-Based Nursing Presents the Archives of Online Journal of Knowledge Synthesis for Nursing, E7, 51–60. doi:10.1111/j.1524-475X.2000.00051.x Selig, B. P., Furr, J. R., Huey, R. W., Moran, C., Alluri, V. N., Medders, G. R., . . . Mulvihill, J. J. (2012). Cancer chemotherapeutic agents as human teratogens. Birth Defects Research Part A: Clinical and Molecular Teratology, 94 (8), 626–650. doi:10.1002/bdra.23063 Sessink, P. J., Connor, T. H., Jorgenson, J. A. e Tyler, T. G. (2011). Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed- system drug transfer device. Journal of Oncology Pharmacy Practice, 17 (1), 39–48. doi:10.1177/1078155210361431 Sessink, P. J., Trahan, J. e Coyne, J. W. (2013). Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device. Hospital Pharmacy, 48 (3), 204–212. doi:10.1310/hpj4803-204 Testa, A., Giachelia, M., Palma, S., Appolloni, M., Padua, L., Tranfo, G., . . . Cozzi, R. (2007). Occupational exposure to antineoplastic agents
Capítulo 6. Manuseio Seguro de Medicamentos Perigosos 161
Powered by FlippingBook